Медицински уређај. Аортни залисци

This tender seeks a transcatheter implantable biological aortic valve with a large diameter delivery system. The absence of specific evaluation criteria and financial requirements suggests a focus on technical merit and compliance. Winning requires a strong demonstration of product superiority, robust clinical evidence, and a clear understanding of the contracting authority's needs, particularly regarding the 'large diameter delivery system' and 'green procurement' aspects.

Superior Clinical Outcomes and Patient Safety

Innovative Delivery System for Enhanced Procedure Efficiency

Commitment to Sustainable Healthcare Solutions

Provide detailed technical specifications, clinical trial data, and evidence of superior performance, particularly focusing on the 'large diameter delivery system' and its benefits. Highlight any certifications or regulatory approvals.

Clearly outline how the product and its supply chain align with green procurement principles. Quantify any environmental benefits (e.g., reduced material usage, energy efficiency in manufacturing, recyclability).

While not explicitly stated, demonstrate how the proposed solution offers long-term value through improved patient outcomes, reduced hospital stays, and potential cost savings in the long run. This can be supported by clinical and economic data.

Provide detailed specifications, performance data, and clinical evidence demonstrating the advantages of the large diameter delivery system. Explain how it simplifies implantation, reduces procedure time, and improves patient outcomes.

Since criteria are not specified, assume a strong focus on technical merit, clinical evidence, and value. Structure the bid to highlight these aspects prominently, providing robust supporting documentation.

Detail specific actions and commitments related to environmental sustainability in product design, manufacturing, packaging, and disposal. Quantify benefits where possible.

Compile all available clinical trial data, post-market surveillance reports, and peer-reviewed publications that demonstrate the safety, efficacy, and superiority of the proposed aortic valve.

Attempt to decode the README.txt file. If unsuccessful, formally request clarification from the contracting authority regarding its content and relevance to the tender.

Beyond initial procurement, describe how the product's lifecycle contributes to sustainability, including end-of-life considerations and potential for material recovery or responsible disposal.

Articulate a clear value proposition that goes beyond just the product, encompassing clinical benefits, procedural efficiency, and long-term cost-effectiveness for the Klaipėda University Hospital.

This tender for biological aortic valves is generally well-structured with clear documentation and a reasonable timeline. However, the absence of disclosed financial value and specific evaluation criteria slightly impacts its completeness and fairness.

The tender adheres to open procedure (2014/24/ES) and includes a CPV code. Deadlines appear reasonable, and general terms and conditions are provided. The primary concern is the lack of a specified reveal date for submissions.

The description of the medical device is clear, and the provided documents outline general and special procurement conditions. Technical requirements are specified, contributing to good clarity.

Most basic information is present, including the contract duration. However, the estimated value is not disclosed, which is a significant omission. While documents are attached, the lack of financial value impacts overall completeness.

The tender is conducted via e-procurement, and the criteria for division into parts are mentioned. The requirements appear objective, and access to documents is provided. The lack of disclosed value is a minor concern for fairness.

The tender is marked as e-procurement, which is positive. However, the specific URL for e-submission is not explicitly provided in the basic information, and financing details are absent. The contract start date is also not specified.

Key fields like title, reference, organization, and CPV code are populated. The dates provided are logical, and there are no reported disputes or suspensions. The tender status is active.

There is no explicit mention of green procurement, social aspects, or innovation. The tender does not indicate if it is EU funded, suggesting a lack of focus on sustainability criteria.